Convergence Diagnostics for Clustered Omics Chains

Why Clustered Omics Chains Need Specialized Diagnostics

A sampler for a Bayesian multi-omics clustering model produces a sequence of possible clusterings, prevalence values, profile parameters, and other model quantities. A long sequence does not by itself show that the sampler has explored the posterior distribution adequately. It may move slowly, remain for many iterations in one region, or fail to visit a distinct region of the posterior. Those problems matter because posterior summaries can then reflect the sampler’s path rather than the target distribution.

Cluster labels require special care. The names “cluster 1” and “cluster 2” are arbitrary: exchanging them may leave the partition and the likelihood unchanged. A trace of “the mean expression in cluster 1” can therefore jump when labels switch, even if the underlying clustering has not changed. Conversely, a chain can appear stable in that parameter because it has not explored alternative labelings or partitions. Convergence assessment should combine ordinary scalar summaries with checks that respect the structure of clustering.

The purpose of these diagnostics is to detect evidence of inadequate exploration, not to prove that a chain has converged. They are most informative when several chains target the same posterior distribution, start from dispersed states, and are monitored on quantities that have meaningful interpretations across label permutations.

Multiple-Chain Summaries and Classical \(\widehat{R}\)

The motivation is that, if chains have explored the same stationary distribution, their means should be broadly compatible, while each chain should also show the distribution’s variation. When chain means remain separated, \(B\) is relatively large and \(\widehat{R}\) tends to exceed 1. A value close to 1 is reassuring for the monitored quantity, but it is not proof of convergence. Chains can share the same failure, and a scalar summary can miss important differences in allocations or tails.

The classical formula assumes that the retained draws are comparable draws from the same target distribution and that each chain has enough iterations for its within-chain variance to be informative. Chains should be run with the same model and data, and initial states should be sufficiently dispersed to make between-chain comparison meaningful. If one chain uses a different target or an inconsistent parameter definition, the comparison is not a convergence diagnostic.

Trace Summaries and Allocation Changes

A trace plot places iteration on the horizontal axis and a monitored quantity on the vertical axis. For a suitable scalar summary, look for sustained trends, long flat stretches, abrupt changes, and differences in the regions occupied by separate chains. A well-mixed trace typically fluctuates through its posterior range without persistent drift, but visual appearance is only one part of assessment. Chains can overlap in a trace while moving so slowly that they provide few effectively independent draws.

For allocations, raw labels are not a stable scale to plot or compare. Instead, compare partitions through label-invariant summaries. One direct comparison checks, for each pair of samples, whether they are assigned to the same cluster. For two partitions of \(N\) samples, a pairwise disagreement fraction is the number of sample pairs whose co-clustering status differs, divided by the total number of pairs, \(N(N-1)/2\). This fraction is a descriptive diagnostic; it is not itself a universal convergence test.

Useful label-invariant trace summaries include the number of occupied clusters, the largest-cluster proportion, sorted cluster proportions, and selected pairwise co-clustering indicators. For example, the indicator that samples \(i\) and \(j\) share a cluster is 1 if they are together and 0 otherwise; it does not depend on the names assigned to clusters. Posterior co-clustering probabilities summarize such indicators across draws, but convergence diagnostics should also examine their behavior across chains and over iterations.

When the number of clusters varies, a trace of “the prevalence of cluster 1” is especially ambiguous. The largest occupied-cluster proportion or a sorted list of occupied proportions is invariant to relabeling, although sorting can itself cause changes in which profile occupies a rank. Monitor the cluster count and allocation summaries alongside relevant model parameters rather than relying on a single number.

Effective Sample Size and Monte Carlo Precision

Autocorrelation means that adjacent draws in a chain carry overlapping information. For a scalar quantity with lag-\(t\) autocorrelation \(\rho_t\), a common approximation to the effective sample size for \(m\) chains of \(n\) draws is $$ \widehat{N}_{\mathrm{eff}}\approx \frac{mn}{1+2\sum_{t=1}^{\infty}\rho_t}. $$ In practice the autocorrelation sum must be estimated and truncated or stabilized; this expression explains the principle, not a license to sum noisy empirical correlations indefinitely. The effective sample size is the approximate number of independent draws that would provide comparable Monte Carlo precision. It is not the number of observations or patients in the study.

For a posterior mean estimated by the average of retained draws, a rough Monte Carlo standard error is \(SE_{\mathrm{MC}}\approx s/\sqrt{\widehat{N}_{\mathrm{eff}}}\), where \(s\) is the sample standard deviation of that quantity. This describes simulation error in estimating the posterior mean, not uncertainty in the scientific parameter itself. A high effective sample size for one quantity does not establish adequate exploration of all aspects of a clustering posterior.

A Practical Diagnostic Sequence and Its Limits

Modern implementations often report split and rank-normalized versions of \(\widehat{R}\). Splitting each chain into portions makes changes in the chain’s behavior more visible, while rank normalization helps diagnose discrepancies for quantities with skewed or heavy-tailed distributions. These improved diagnostics are generally preferable to relying only on the classical formula, but they still assess selected summaries and cannot guarantee exploration of every posterior mode.

A diagnostic failure can arise because chains have not mixed, because the posterior has separated regions that are difficult to traverse, or because the monitored quantity is poorly chosen. For clustering, the sampler may remain in a particular partition for many iterations even while continuous profile parameters appear stable. Conversely, rapid label switching can make a raw cluster-specific trace look unstable although the partition-level summaries are stable. Examine both model quantities and label-invariant allocation behavior before deciding what the evidence means.

The main alternatives are complementary rather than interchangeable. Trace inspection can reveal patterns that a single number hides, but it is subjective and cannot quantify Monte Carlo precision. \(\widehat{R}\) compares chains for a chosen summary, but values near 1 do not rule out shared trapping or unmonitored problems. Effective sample size addresses dependence and simulation precision, but it is summary-specific. Allocation comparisons detect changes in partitions without depending on label names, but disagreement alone cannot distinguish poor mixing from posterior uncertainty. No one diagnostic replaces the others.

Common Pitfalls

• Reading labels as identities. A change from cluster 1 to cluster 2 need not be a change in the partition. Compare co-clustering or other label-invariant summaries.
• Treating \(\widehat{R}\) near 1 as proof. It is evidence about the monitored quantity and chains, not a certificate that the full posterior has been explored.
• Ignoring allocation behavior. Stable means for profile parameters do not guarantee that chains have explored alternative sample partitions.
• Calling effective sample size a sample size. It concerns Monte Carlo information in the draws, not the number of samples or features in the omics study.
• Interpreting chain disagreement as automatically bad. Chains can differ because the posterior genuinely assigns uncertainty to competing partitions. The question is whether each chain explores the target distribution adequately.

These diagnostics matter because downstream posterior summaries are only as dependable as the sampling that produced them. When evidence of poor mixing remains, reporting a precise-looking cluster assignment or profile summary can overstate what the computation supports. Report the quantities monitored and the diagnostic evidence, and treat unresolved warnings as limitations rather than as proof that the model is wrong or right.